Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

NCT01726582 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Milestone 1: Targeted chemotherapy prior to surgery
RADIATION: Milestone 2: Chemoradiotherapy (cXRT)
DRUG: Milestone 3: Targeted chemotherapy prior to surgery
RADIATION: Milestone 3: Chemoradiotherapy (cXRT)
DRUG: Milestone 4: standard FOLFIRINOX chemotherapy prior to surgery
RADIATION: Milestone 4: Chemoradiotherapy (cXRT)
DRUG: Milestone 5: Targeted chemotherapy after surgery
RADIATION: Milestone 5: Chemoradiotherapy (cXRT)
DRUG: Milestone 6: Gemcitabine after surgery
RADIATION: Milestone 6: Chemoradiotherapy (cXRT)
RADIATION: Milestone 7: Chemoradiotherapy (cXRT)
DRUG: Milestone 8: Targeted chemotherapy after surgery
DRUG: Milestone 9: Gemcitabine after surgery
OTHER: Milestone 10: No additional therapy after surgery

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]